Bronchodilator effect of atrial natriuretic peptide in asthma G Hulks, A Jardine, J M C Connell,
N C Thomson
Atrial natriuretic peptide relaxes vascular smooth muscle directly, but little interest has been expressed in its effect on airway smooth muscle despite an in vitro study showing a dose dependent relaxant effect on guinea pig trachea.' This effect has since been observed on tone induced by agonists in vitro,2 and a recent in vivo study showed that infusions of atrial natriuretic peptide increased basal airway conductance and reversed bronchoconstriction induced by leukotriene D4 in the same animal model. 3 We examined the effect of infused atrial natriuretic peptide on bronchomotor tone in asthmatic subjects.
Subjects, methods, and results
We studied eight subjects (two women; mean (SD) age 39 7 (8 8) years). Each had moderately severe asthma: mean forced expiratory volume in one second was 47-2 (9-8)% of the predicted value and was improved in each subject by >25% by inhaled salbutamol. Inhaled bronchodilator agents were withheld for 10 hours, but other inhaled treatment was continued as usual. Written informed consent was obtained and the study approved by Glasgow West ethical committee.
On each of two study days an indwelling venous cannula was inserted into each forearm and the subject relaxed for 20 minutes. We then measured forced expiratory volume in one second (taken as the best of three attempts) with a dry wedge spirometer (Vitalograph) and blood pressure and pulse rate with a semiautomatic sphygmomanometer; we withdrew 20 ml blood to estimate plasma atrial natriuretic peptide concentration by radioimmunoassay4 and catecholamine concentrations. After these baseline measurements an intravenous infusion ofeither atrial natriuretic peptide or placebo was administered in a double blind, randomised manner. Doses ofpeptide corresponded to 0 5, 2 0, and 10 0pmol/kg/min and were given for 20 minutes each in incremental fashion. At the end of each infusion period forced expiratory volume in one second, pulse, blood pressure, and atrial natriuretic peptide and catecholamine concentrations were measured. After the last dose had been completed the infusion was stopped and each subject received 5 mg nebulised salbutamol; final measurements were taken 20 minutes thereafter. The significance of the data was assessed by two way analysis of variance.
The forced expiratory volume in one second rose significantly at the highest rate of infusion with a mean increase of 0 50 (95% confidence interval 0-23 to 0-78) litre (equivalent to 31-5 (14-9 to 48-1)%) from the baseline value (p<0-01; figure) . It tended to rise at an Rate of infusion (pmol/kg/min) Mean change in forced expiratory volume in one second with varying rates of intravenous infusion of atrial natriuretic peptide compared with placebo (n=8). Nebulised salbutamol (5mg) was given after final infusion. Vertical bars represent 95% confidence intervals infusion rate of 2 pmol/kg/min, but this was not significant. Overall, the response varied considerably: some subjects responded appreciably to the middle infusion dose while one subject did not respond at all even to the highest dose. No side effects were reported during the active and placebo studies. The mean plasma atrial natriuretic peptide concentration was 10 (95% confidence interval 6 to 15) nmol/l basally (normal 2-17 nmol/1); this rose to 12 (8 to 16) nmol/l, 43 (33 to 53) nmol/l, and 252 (220 to 285) nmol/l with increasing rates of infusion and had fallen to 12 (11 to 18) nmol/l 20 minutes after salbutamol.
Baseline pulse, blood pressure, and catecholamine concentrations were comparable, and variation in these measurements between the two study days was not significant.
Comment
We believe this to be the first report of the effects of atrial natriuretic peptide in asthmatic subjects; we found that it had considerable bronchodilator properties. In many tissues atrial natriuretic peptide alters intracellular events through generating cyclic guanosine monophosphate, and preliminary evidence suggests that a similar action occurs in tracheal smooth muscle.5 Although specific receptors have been identified in pulmonary tissue, they have not so far been found in airway smooth muscle. In lung disease atrial natriuretic peptide has been assumed to act as a pulmonary vasodilator in addition to having peripheral renal and vascular action. Our findings suggest that important effects on airway tone may also occur; further studies to explore the peptide's role in pulmonary physiology and disorders of airway tone are indicated. We evaluated the usual methods of drug detection in 50 subjects who were suspected of quick swallowing of drugs and we also gave them an emetic.
Subjects, methods, and results
Sixty five subjects were referred to the forensic emergencies department in 1988 on suspicion of having swallowed packets of drugs up to two hours before admission. Fifty accepted both a urine analysis and an oral emetic drug. A urine sample was analysed on admission as previously described.2 A dose of 15 ml ipecacuanha syrup was given with 200 ml water and repeated once if necessary. In 20 of the 50 subjects supine plain abdominal films were taken to try to detect foreign bodies. Quick swallowing of drugs was considered proved when wrappings or packages were recovered in emesis. The results of drug detection by urine analysis and by abdominal radiography were categorised as follows: (a) positive-positive urine result and wrappings recovered; (b) false positivepositive urine result and no wrappings recovered; (c) false negative -negative urine result and wrappings recovered; (d) negative-negative urine results and no wrappings recovered. The accuracy of both tests was estimated by the sensitivity (a/(a+c)), specificity (dl(b+d)), and percentage of correct classifications ((a+d) divided by number of results).
All but three subjects were conscious and their 
Comment
Ten of 50 subjects had evidence of toxicity from ingesting drugs-a higher incidence than in cases of body packing of packets that are made to be ingested. 3 The methods of managing drug ingestion in body packers are unsuitable for dealers who quick swallow their drugs because drug concentrations were not consistently detected in urine samples-a sensitive but non-specific test-and the images on radiographs were not distinct. Subjects who conceal drugs by swallowing require quick evacuation ofgastric contents to avert toxicity. We tried using a stomach tube, but most subjects did not comply, whereas they usually accepted induced emesis. As performed in alert subjects, this seemed to be safe, and packets or wrappings were retrieved in half of the suspected subjects.
